Last reviewed · How we verify
NCT05509231
Effects of a Multimodal Exercise Program for Children With ASD
NA trial testing High-intensity exercise in Autism Spectrum Disorder in 50 participants. Status unknown.
31 January 2024
Quick facts
| Lead sponsor | New York Institute of Technology |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 12 January 2024 |
| Primary completion | 31 January 2024 |
| Estimated completion | 31 January 2024 |
Drugs / interventions tested
- High-intensity exercise
- Wearable glove and arm sleeve device to measure movement
Conditions studied
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Asperger Syndrome — all drugs for Asperger Syndrome →
Sponsor
New York Institute of Technology
Who can join
Adults 6 to 27, any sex, with Autism Spectrum Disorder or Asperger Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Exploring the effects of an exercise program for children ages 6 -26 years old who have been diagnosed with autism spectrum disorder and neurotypical children respond to high-intensity whole body exercise interventions (Group 1), training using a sensory glove and armband (Group 2), no-intervention control (waitlist control) (Group 3). Approximately 50 children and adolescents will volunteer to participate in this program with participants parents' (or legal guardians') permission. This study will be conducted at an off-site pediatric occupational therapy facility Inclusive Sports and Fitness, Inc. (ISF).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05509231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
- NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting
Other New York Institute of Technology trials
Trials by the same sponsor.
- NCT07341204 — How Virtual Reality Can Help Neurodivergent Children Improve Their Attention · NA · not yet recruiting
- NCT07362329 — Use of Exercise Snacks to Improve Upper Body Fitness · NA · active not recruiting
- NCT07218614 — Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Sm · NA · not yet recruiting
- NCT06671600 — Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects · NA · not yet recruiting
- NCT06546462 — Can a Specific OMT Protocol Influence Patient Pain and Associated Analgesia Use for Primary Headache Disorders? · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509231 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York Institute of Technology
- Last refreshed: 13 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing